The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study

Overview

Journal Am J Transplant

Publisher Elsevier

Specialty General Surgery

Date 2017 Mar 22

PMID 28321975

Citations 44

Authors

E Shemesh

J C Bucuvalas

R Anand

G V Mazariegos

E M Alonso

R S Venick

M Reyes-Mugica

R A Annunziato

B L Shneider

Affiliations

Soon will be listed here.

Abstract

Nonadherence to immunosuppressant medications is a leading cause of poor long-term outcomes in transplant recipients. The Medication Level Variability Index (MLVI) provides a vehicle for transplant outcome risk-stratification through continuous assessment of adherence. The MALT (Medication Adherence in children who had a Liver Transplant) prospective multi-site study evaluated whether MLVI predicts late acute rejection (LAR). Four hundred pediatric (1-17-year-old) liver transplant recipients were enrolled and followed for 2 years. The a-priori hypothesis was that a higher MLVI predicts LAR. Predefined secondary analyses evaluated other outcomes such as liver enzyme levels, and sensitivity analyses compared adolescents to pre-adolescents. In the primary analysis sample of 379 participants, a higher prerejection MLVI predicted LAR (mean prerejection MLVI with LAR: 2.4 [3.6 standard deviation] versus without LAR, 1.6 [1.1]; p = 0.026). Fifty-three percent of the adolescents with MLVI>2 in year 1 had LAR by the end of year 2, as compared with 6% of those with year 1 MLVI≤2. A higher MLVI was significantly associated with all secondary outcomes. MLVI, a marker of medication adherence that uses clinically derived information, predicts LAR in pediatric liver transplant recipients.

Citing Articles

Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes.

Zhi-Yu Z, Lin-Rui D, Chen-Zhen Y, Ren-Jie C, Fei-Hong Y, Song C Front Pharmacol. 2025; 15:1493166.

PMID: 39744122 PMC: 11688411. DOI: 10.3389/fphar.2024.1493166.

Cardiovascular Precision Medicine and Remote Intervention Trial Rationale and Design.

Reynolds D, Annunziato R, Sidhu J, Cotter G, Davison B, Takagi K J Clin Med. 2024; 13(20).

PMID: 39458224 PMC: 11509108. DOI: 10.3390/jcm13206274.

Cross-cultural validation of the Spanish version of the Kidney AlloTransplant Immunosuppressive Therapy Adherence Questionnaire (KATITA-25).

de Medeiros Oliveira L, Pedreira-Robles G, Perez-Saez M, Crespo M, Bach-Pascual A, Rubio-Paez S Sci Rep. 2024; 14(1):24287.

PMID: 39414895 PMC: 11484981. DOI: 10.1038/s41598-024-75150-5.

Changes in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients.

Killian M, Little C, Mayewski S Clin Transplant. 2024; 38(10):e15442.

PMID: 39385672 PMC: 11469551. DOI: 10.1111/ctr.15442.

Impact of Intrapatient Immunosuppression Variability in Liver Transplantation Outcomes: A Systematic Review and Meta-analysis.

Lattimore S, Chambers A, Angeli-Pahim I, Shrestha A, Eke B, Pomputius A Transplant Direct. 2024; 10(9):e1700.

PMID: 39188531 PMC: 11346865. DOI: 10.1097/TXD.0000000000001700.

References

Jeffery R, Navarro T, Wilczynski N, Iserman E, Keepanasseril A, Sivaramalingam B . Adherence measurement and patient recruitment methods are poor in intervention trials to improve patient adherence. J Clin Epidemiol. 2014; 67(10):1076-82. DOI: 10.1016/j.jclinepi.2014.06.008. View

Shemesh E . Barriers to adherence - To screen or not to screen, that is the question. Pediatr Transplant. 2016; 20(2):188-90. DOI: 10.1111/petr.12671. View

Molloy G, OCarroll R, Witham M, McMurdo M . Interventions to enhance adherence to medications in patients with heart failure: a systematic review. Circ Heart Fail. 2012; 5(1):126-33. DOI: 10.1161/CIRCHEARTFAILURE.111.964569. View

Kelly D, Bucuvalas J, Alonso E, Karpen S, Allen U, Green M . Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013; 19(8):798-825. DOI: 10.1002/lt.23697. View

Demetris A, Adeyi O, Bellamy C, Clouston A, Charlotte F, Czaja A . Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006; 44(2):489-501. DOI: 10.1002/hep.21280. View

Danziger-Isakov L, Frazier T, Worley S, Williams N, Shellmer D, Dharnidharka V . Perceived barriers to medication adherence in pediatric and adolescent solid organ transplantation. Pediatr Transplant. 2015; 20(2):307-15. PMC: 6422022. DOI: 10.1111/petr.12648. View

Annunziato R, Baisley M, Arrato N, Barton C, Henderling F, Arnon R . Strangers headed to a strange land? A pilot study of using a transition coordinator to improve transfer from pediatric to adult services. J Pediatr. 2013; 163(6):1628-33. DOI: 10.1016/j.jpeds.2013.07.031. View

Reese P, Bloom R, Trofe-Clark J, Mussell A, Leidy D, Levsky S . Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial. Am J Kidney Dis. 2016; 69(3):400-409. DOI: 10.1053/j.ajkd.2016.10.017. View

Shemesh E, Lurie S, Stuber M, Emre S, Patel Y, Vohra P . A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics. 2000; 105(2):E29. DOI: 10.1542/peds.105.2.e29. View

10.

Shellmer D, Zelikovsky N . The challenges of using medication event monitoring technology with pediatric transplant patients. Pediatr Transplant. 2007; 11(4):422-8. PMC: 3671915. DOI: 10.1111/j.1399-3046.2007.00681.x. View

11.

Bucuvalas J, Alonso E, Magee J, Talwalkar J, Hanto D, Doo E . Improving long-term outcomes after liver transplantation in children. Am J Transplant. 2008; 8(12):2506-13. DOI: 10.1111/j.1600-6143.2008.02432.x. View

12.

Porter M . What is value in health care?. N Engl J Med. 2010; 363(26):2477-81. DOI: 10.1056/NEJMp1011024. View

13.

Lieber S, Volk M . Non-adherence and graft failure in adult liver transplant recipients. Dig Dis Sci. 2012; 58(3):824-34. DOI: 10.1007/s10620-012-2412-0. View

14.

Shemesh E, Annunziato R, Shneider B, Dugan C, Warshaw J, Kerkar N . Improving adherence to medications in pediatric liver transplant recipients. Pediatr Transplant. 2008; 12(3):316-23. DOI: 10.1111/j.1399-3046.2007.00791.x. View

15.

Christina S, Annunziato R, Schiano T, Anand R, Vaidya S, Chuang K . Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Liver Transpl. 2014; 20(10):1168-77. PMC: 4177441. DOI: 10.1002/lt.23930. View

16.

Stuber M, Shemesh E, Seacord D, Washington 3rd J, Hellemann G, McDiarmid S . Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Transplant. 2008; 12(3):284-8. DOI: 10.1111/j.1399-3046.2008.00923.x. View

17.

Jayaraman S, Rieder M, Matsui D . Compliance assessment in drug trials: has there been improvement in two decades?. Can J Clin Pharmacol. 2005; 12(3):e251-3. View

18.

Venkat V, Nick T, Wang Y, Bucuvalas J . An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence. Pediatr Transplant. 2008; 12(1):67-72. DOI: 10.1111/j.1399-3046.2007.00794.x. View

19.

Shemesh E, Fine R . Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients?. Pediatr Transplant. 2010; 14(8):940-3. PMC: 2992596. DOI: 10.1111/j.1399-3046.2010.01396.x. View

20.

Pai A, Rausch J, Tackett A, Marsolo K, Drotar D, Goebel J . System for integrated adherence monitoring: real-time non-adherence risk assessment in pediatric kidney transplantation. Pediatr Transplant. 2012; 16(4):329-34. DOI: 10.1111/j.1399-3046.2012.01657.x. View